证券记录 · 已归档季度
EVH
Evolent Health, Inc. · Healthcare · Medical - Healthcare Information Services
19被追踪持有人
+1Δ持有人
60.10M持有股份
$508.46M报告持仓市值
+2新建仓位
−2清仓
动量输入（同类管理人）：
持有人广度 +5.6% ·
股份流向 +12.0% ·
净新建仓位 0.0%
· 公式
广泛增持：持股数量上升，持有人数量增加
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q3 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 78 | +6 | 70.64M | $382.54M | +11 | −4 |
| Q1 2026 | 73 | -12 | 65.20M | $148.81M | +7 | −20 |
| Q4 2025 | 86 | 0 | 77.77M | $307.90M | +1 | n/a |
| Q3 2025 | 19 | +1 | 60.10M | $508.46M | +2 | −2 |
| Q2 2025 | 16 | -1 | 36.98M | $416.34M | n/a | −1 |
| Q1 2025 | 14 | 0 | 22.70M | $214.97M | +1 | −1 |
| Q4 2024 | 14 | +1 | 27.38M | $247.73M | +1 | n/a |
| Q3 2024 | 12 | 0 | 21.00M | $593.78M | +1 | −1 |
| Q2 2024 | 12 | n/a | 19.79M | $378.42M | n/a | n/a |
持有人 · Q3 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (被动) | 10.97M | +0.4% | $92.78M | 0.0% | ▲ Add | 2 | SEC ↗ ×5 |
| 2 | BlackRock ✦ (被动) | 9.31M | -0.7% | $78.80M | 0.0% | ▼ Trim | 2 | SEC ↗ ×16 |
| 3 | Fidelity (FMR) ✦ | 8.75M | +36.3% | $74.02M | 0.0% | ▲ Add | 2 | SEC ↗ ×5 |
| 4 | JPMorgan Chase ✦ | 8.00M | n/a | $67.70M | 0.0% | n/c | 1 | SEC ↗ ×16 |
| 5 | Morgan Stanley ✦ | 7.98M | n/a | $67.50M | 0.0% | n/c | 1 | SEC ↗ ×15 |
| 6 | State Street Global Advisors ✦ (被动) | 2.97M | +0.1% | $25.16M | 0.0% | ▲ Add | 4 | SEC ↗ ×2 |
| 7 | Geode Capital Management ✦ (被动) | 2.76M | +3.4% | $23.33M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 8 | D. E. Shaw & Co. ✦ | 2.74M | +30.1% | $23.16M | 0.0% | ▲ Add | 4 | SEC ↗ ×4 |
| 9 | Citadel Advisors ✦ | 2.30M | +291.3% | $19.43M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 10 | Goldman Sachs Group ✦ | 881.34K | n/a | $7.46M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 11 | Two Sigma Investments ✦ | 851.14K | +133.8% | $7.20M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 12 | Marshall Wace ✦ | 654.75K | +2345.0% | $5.54M | 0.0% | ▲ Add | 6 | SEC ↗ ×3 |
| 13 | Point72 Asset Management ✦ | 601.98K | 新增 | $5.09M | 0.0% | New | 1 | SEC ↗ |
| 14 | Millennium Management ✦ | 456.62K | -27.5% | $3.86M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 15 | Renaissance Technologies ✦ | 310.10K | 新增 | $2.62M | 0.0% | New | 1 | SEC ↗ |
| 16 | GAMCO Investors ✦ | 244.00K | -0.5% | $2.06M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 17 | Adage Capital Partners ✦ | 188.52K | -34.7% | $1.59M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 18 | T. Rowe Price ✦ | 115.76K | +9.4% | $980,000 | 0.0% | ▲ Add | 6 | SEC ↗ |
| 19 | AQR Capital Management ✦ | 18.50K | -10.7% | $156,517 | 0.0% | ▼ Trim | 5 | SEC ↗ ×4 |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| Point72 Asset Management | $5.09M | 0.0% |
| Renaissance Technologies | $2.62M | 0.0% |
已清仓
| Norges Bank | $2.02M | 曾为 0.0% |
| Wellington Management | $729,986 | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 1 持有人, 7.50M 股份, $3.77M 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Aug 26
McCarthy Daniel Joseph
Officer · 65.89K 股 · $329,460
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
Sep 08
SC 13G/A: MORGAN STANLEY
Jul 17
SC 13G: BlackRock Portfolio Management LLC
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q3 2025 ·
方法论 ·
通过API获取此数据